Applied Clinical Trials-12-01-2018

First column in this series looks at the effectiveness of digital marketing as an outreach tool.

European Union faces a critical view on its pediatric drug development situation, highlighting a lack of treatment, infrastructure, reimbursement, and regulatory agreement.

Supporting real change in clinical trials is more than just lip service-it’s putting the information out there transparently for all stakeholders to measure and make decisions.

New FDA guidances outlining recommended approaches for clinical testing methods and collecting research data, alongside with public workshops and meetings, accelerate reviews to speed new therapies to market.

IACT Health executive talks to Applied Clinical Trials about the importance of increased professional and technology investment at clinical trial sites.

Examining the barriers, challenges, and outcomes to determine the effectiveness of different RBM implementation approaches.

New study reveals that inconsistent, tactical, and reactive outsourcing practices predominate.

With cloud-based software dominating data systems, on-premise installations still exist and command the pharmacovigilance software market.

Click the title above to open the Applied Clinical Trials December 2018 issue in an interactive PDF format.

Outlining the potential of three mHealth technology approaches in enabling novel and more robust clinical outcomes measurements.

The availability of FHIR-based APIs enabling patients to access and use their healthcare data for multiple purposes has opened a door to an entirely new world of opportunities for partnering with patients on clinical studies.

Have you seen many paradigm shifts lately?

Survey highlights thoughts on digital integration, managing data sources.

Survey uncovers key findings amid today’s explosion of data volume and sources-and the added complexity in managing clinical data.